Meningioma
📧 Sign up to get email alerts when something new happens for Meningioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients.
The study completed an investigation into biomarkers predicting response to proton beam therapy in pediatric and adult patients with brain c…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy [Phase 2]
A Phase 2 clinical trial is evaluating Lutathera for inoperable, progressive meningioma after external beam radiation therapy, currently rec…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment [Phase 2]
An ongoing Phase 2 clinical trial evaluating Lutetium-177 dotatate ([177Lu]Lu-DOTATATE) versus standard of care for recurrent intracranial m…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma [Phase 2]
A Phase 2 clinical trial evaluating JZP3507 (ONC206) in recurrent Grade 2 or 3 meningioma, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma [Phase 2]
A Phase 2 clinical trial update evaluating stereotactic radiosurgery with pembrolizumab for recurrent meningioma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas [NA]
This clinical trial update describes a study evaluating increased dose intensity-modulated proton therapy (IMPT) for high-grade meningiomas;…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Lutathera (lutetium-177 dotatate) for recurrent or progressive high-grade central nervous system tumor…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating nivolumab with multi-fraction stereotactic radiosurgery, with or without ipilimumab, for recurrent Gra…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas [Phase 2]
Phase 2 study evaluating a combination of vismodegib, defactinib, capivasertib, and abemaciclib for intracranial or recurrent meningioma, in…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures [NA]
This clinical trial compares intradermal running sutures with transdermal interrupted sutures for skin closure in oncologic neurosurgical pr…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: ITM11 Expanded Access Program
The ITM11 expanded access program for meningioma is currently available, allowing eligible patients to access the investigational product ou…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures [EARLY_Phase 1]
This document describes a NOT_YET_RECRUITING Phase 1 pilot study evaluating Panitumumab-IRDye800 as an optical imaging agent to detect intra…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: MiDura-Study (Neuro-Patch in Duraplasty)
MiDura-Study evaluating a Neuro-Patch in duraplasty is currently active but not recruiting, with conditions including meningioma and several…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Abemaciclib in Newly Diagnosed Meningioma Patients [Phase 2]
This clinical trial update indicates a Phase 2 study of abemaciclib in newly diagnosed meningioma patients is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Plasma Extracellular Vesicles in Meningioma Patients [NA]
A clinical trial at University Hospital Heidelberg is investigating plasma extracellular vesicles in patients with meningioma to explore pot…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
An ongoing clinical trial is recruiting to study the frequency and clinical phenotype of BAP1 tumor predisposition syndrome and its associat…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients [EARLY_Phase 1]
An early-phase clinical trial update evaluating ribociclib (LEE011) in preoperative glioblastoma and meningioma patients.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Cabozantinib for Patients With Recurrent or Progressive Meningioma [Phase 2]
A Phase 2 clinical trial is evaluating cabozantinib in patients with recurrent or progressive meningioma and is currently recruiting at Bapt…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: NEO100 and High-Grade Meningioma [Phase 2]
Phase 2 clinical trial evaluating NEO100 for residual, progressive, or recurrent Grade II or III meningioma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE [Phase 4]
A Phase 4 clinical trial is evaluating the feasibility of using copper-64 labeled DOTATATE ([Cu64]DOTATATE) for intraoperative tracing of me…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma [Phase 2]
Phase 2 clinical trial update for Zanzalintinib in recurrent or progressive meningioma; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Measurement of PSMA Expression in Vivo in Recurrent Meningiomas by PET Imaging: a Preliminary Study to a Therapeutic Trial Using Radioligand Therapy (RLT) [NA]
Preliminary study using PSMA PET imaging to measure PSMA expression in recurrent meningiomas, aiming to support a planned radioligand therap…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
This clinical trial examines tumor genomics, individual risk factors, and external health drivers to understand outcomes in patients with me…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors
This clinical trial update indicates the study analyzing cerebrospinal fluid leakage after intracranial tumor surgery is currently recruitin…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
GT Medical Technologies reports that the STaRT GammaTiles brain tumor trial is currently recruiting patients with various brain tumors, incl…